Back to Top
World Gastroenterology Organisation
World Gastroenterology Organisation
WGO: Facebook WGO: Twitter

Management of Strongyloidiasis

Level: Meta-analyses, Systematic reviews, Practice guidelines: 17 Abstracts

Legend: : Key Development,  : Very Important,  : Important, [no star]: Special Mention


Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis.
E Gotuzzo, J Moody, K Verdonck, MM Cabada, E González, S Van Dooren, AM Vandamme, A Terashima, SH Vermund, Rev Panam Salud Publica. 2007 Oct:223-30


Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait.
T Said, MR Nampoory, MP Nair, MA Halim, SA Shetty, AV Kumar, E Mokadas, A Elsayed, KV Johny, M Samhan, M Al-Mousawi, Transplant Proc. 2007 May:1014-5


Immunocompromised group differences in the presentation of intestinal strongyloidiasis.
P Vaiyavatjamai, JJ Boitano, P Techasintana, A Tungtrongchitr, Jpn J Infect Dis. 2008 Jan:5-8


Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey.
DR Boulware, WM Stauffer, BR Hendel-Paterson, JL Rocha, RC Seet, AP Summer, LS Nield, K Supparatpinyo, R Chaiwarith, PF Walker, Am J Med. 2007 Jun:545.e1-8


Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
M Segarra-Newnham, Ann Pharmacother. 2007 Dec:1992-2001


Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review.
L Fardet, T Généreau, JL Poirot, B Guidet, A Kettaneh, J Cabane, J Infect. 2007 Jan:18-27


Strongyloides stercoralis infection.
Greaves D(1), Coggle S, Pollard C, Aliyu SH, Moore EM., BMJ. 2013 Jul 30;347:f4610. doi: 10.1136/bmj.f4610.


Neglected tropical diseases: survey and geometry of randomised evidence.
Kappagoda S, Ioannidis JP., BMJ. 2012 Oct 22;345:e6512. doi: 10.1136/bmj.e6512.


Eosinophilia and the seroprevalence of schistosomiasis and strongyloidiasis innewly arrived pediatric refugees: an examination of Centers for Disease Controland Prevention screening guidelines.
Dawson-Hahn EE, Greenberg SL, Domachowske JB, Olson BG., J Pediatr. 2010 Jun;156(6):1016-8, 1018.e1. Epub 2010 Apr 18.


Identification of a 26-kDa protein fraction as an important antigen for application in the immunodiagnosis of strongyloidiasis.
AP Sudré, RC Siqueira, MG Barreto, RH Peralta, HW Macedo, JM Peralta, Parasitol Res. 2007 Sep:1117-23


IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen.
RM Rodrigues, MC de Oliveira, MC Sopelete, DA Silva, DM Campos, EA Taketomi, JM Costa-Cruz, Parasitol Res. 2007 Oct:1209-14


Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
T Hirata, N Uchima, K Kishimoto, O Zaha, N Kinjo, A Hokama, H Sakugawa, F Kinjo, J Fujita, Am J Trop Med Hyg. 2006 Feb:246-9


Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method.
T Hirata, H Nakamura, N Kinjo, A Hokama, F Kinjo, N Yamane, J Fujita, Am J Trop Med Hyg. 2007 Oct:683-4


Invasive enteric infections in hospitalized patients with underlying strongyloidiasis.
MN Al-Hasan, M McCormick, JA Ribes, Am J Clin Pathol. 2007 Oct:622-7


Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis.
H Karunajeewa, H Kelly, D Leslie, J Leydon, P Saykao, BA Biggs, J Travel Med. 2006 Mar-Apr:84-91


Strongyloides venezuelensis: The antigenic identity of eight strains for the immunodiagnosis of human strongyloidiasis.
ER Machado, LH Faccioli, JM Costa-Cruz, EV Lourenço, MC Roque-Barreira, Mdo R Gonçalves-Pires, MT Ueta, Exp Parasitol. 2008 May:7-14


Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
FM Marty, CM Lowry, M Rodriguez, DA Milner, WS Pieciak, A Sinha, L Fleckenstein, LR Baden, Clin Infect Dis. 2005 Jul 1:e5-8